Ozempic, ursprünglich als Diabetes-Medikament entwickelt, wird gerne zur Gewichtsabnahme genutzt. Doch die Verwendung kann gravierende Folgen für den Körper haben.

Schluss mit langweiligen Strumpfhosen! Im Frühling 2025 setzen wir auf Farbe! Im Video zeigen wir Ihnen den Strumpfhosen-Trend des Jahres.

Die Stars verlieren ihre Kurven. Dahinter sollen Abnehmspritzen stecken. In Hollywood wird der Trend offenbar auf speziellen ...

Demand for weight-loss medications, including popular brands like Ozempic and Wegovy, continues to rise. A recent study revealed that one in eight Americans has used or is currently using these drugs ...

NEW YORK, Jan. 22 (UPI) --As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a new study has uncovered neurological and behavioral health ...

She ended up taking a second job to afford it. When Rice reached her goal weight, she tried phasing out semaglutide (marketed as Wegovy for weight loss and Ozempic for diabetes), using smaller and ...

This class of drugs, known as glucagon-like peptide-1 receptor agonists, or GLP-1s, also includes Wegovy and Zepbound. GLP-1s were developed to treat diabetes, but they have become popular weight ...

In the obesity space, Novo Nordisk reported data from a Phase III trial showing that a high dose of Wegovy elicited more weight loss than the approved regimen—but still fell short of results posted by ...

Ozempic and Wegovy have been added to Medicare's list of drugs whose prices will be negotiated between drug makers and the government. There's a lot of uncertainty on which direction the Trump ...

Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing dozens of health conditions. But the semaglutide-like drugs also appear to ...

Results from the STEP UP trial show that a high-dose formulation of Wegovy can significantly increase the weight loss effects the drug is known for. Novo Nordisk has announced topline results from the ...

Forscher der Washington University haben die Effekte von GLP-1-Rezeptor-Agonisten wie Wegovy umfassend untersucht. Wie die «Zeit» berichtet, zeigt die Studie sowohl Vorteile als auch Risiken dieser ...